| JYSB2100048 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-02-19 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | In Review | 2021-02-18 | view |
| JYSB2100047 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-02-19 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | In Review | 2021-02-18 | view |
| JYSB2100046 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-02-19 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | In Review | 2021-02-18 | view |
| JYSB2100045 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-02-19 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | In Review | 2021-02-18 | view |
| JYSB2000399 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Filed | 2020-09-15 | view |
| JYSB2000398 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Filed | 2020-09-15 | view |
| JYSB2000397 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Filed | 2020-09-15 | view |
| JYSB2000400 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Filed | 2020-09-15 | view |
| JYSB2000372 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-10 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Filed | 2020-08-19 | view |
| JYSB2000371 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-10 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Filed | 2020-08-19 | view |
| JYSB2000374 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-10 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Filed | 2020-08-19 | view |
| JYSB2000373 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-10 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Filed | 2020-08-19 | view |
| JYSB1800271 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2018-12-03 | | Pfizer Ltd | Certificate Issued | 2019-12-20 | view |
| JYSB1800270 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2018-12-03 | | Pfizer Ltd | Certificate Issued | 2019-12-20 | view |
| JYSB1800273 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2018-12-03 | | Pfizer Ltd | Certificate Issued | 2019-12-20 | view |
| JYSB1800272 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2018-12-03 | | Pfizer Ltd | Certificate Issued | 2019-12-20 | view |
| JXSS1900065 | 注射用重组人凝血因子IX -Fc融合蛋白 | eftrenonacog alfa | Lyophilized | Biological Products | Import Drug Application | 2019-11-27 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Bioverativ Therapeutics Inc | In Review | 2019-12-14 | view |
| JXSS1900064 | 注射用重组人凝血因子IX -Fc融合蛋白 | eftrenonacog alfa | Lyophilized | Biological Products | Import Drug Application | 2019-11-27 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Bioverativ Therapeutics Inc | In Review | 2019-12-14 | view |
| JXSS1900063 | 注射用重组人凝血因子IX -Fc融合蛋白 | eftrenonacog alfa | Lyophilized | Biological Products | Import Drug Application | 2019-11-27 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Bioverativ Therapeutics Inc | In Review | 2019-12-14 | view |
| JXSS1900062 | 注射用重组人凝血因子IX -Fc融合蛋白 | eftrenonacog alfa | Lyophilized | Biological Products | Import Drug Application | 2019-11-27 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Bioverativ Therapeutics Inc | In Review | 2019-12-14 | view |
